Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 121 results.

Pages

Online customer reviews of products and services have become increasingly important in the marketplace. Many consumers rely on them to decide what to buy or where to buy it, and many companies rely on them to attract customers and stand out from the pack. That was true even before the...
It’s the oldest trick in the book: Now you see it, now you don’t. This illusion is fine on a Las Vegas stage, but on an online retailer’s website, making negative reviews disappear is hardly magical. The FTC calls it review suppression – and companies engaging in this practice will be...
The Federal Trade Commission ordered more than 20 marketers nationwide to immediately stop making baseless claims that their products and supposed therapies can treat or prevent COVID-19. In cease-and-desist demands sent to these marketers, the agency noted that violators could be hit with monetary...
The Federal Trade Commission is sending 71,899 checks totaling more than $1.8 million to consumers, including many older Americans, tricked into paying for supposedly free in-home medical alert devices. The money comes from a settlement with New York-based Lifewatch, Inc.
The Federal Trade Commission is sending refund payments totaling more than $1.1 million to consumers who bought three supplements deceptively marketed as treatments for pain and other health conditions related to aging.
The Federal Trade Commission sent cease-and-desist letters to 10 companies suspected of advertising unproven treatments or cures for diabetes, ordering the companies to stop making unsubstantiated claims within 15 days or face potential legal action by the FTC.
Following a public comment period, the Federal Trade Commission has approved a final administrative consent order against Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the company’s owner, Cody Alt, for allegedly making false or unsupported health claims during the marketing and sale...
The Federal Trade Commission charged an online marketer with falsely promising consumers that he could quickly deliver facemasks and other personal protective equipment during the COVID-19 pandemic, then failing to deliver on customers’ orders or offer cancellations or refunds.
The medical director of California-based Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19. Dr. Stephen Meis will be barred from making similar...
Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against three companies, BASF SE, its subsidiary, BASF Corp.
The Federal Trade Commission has joined the U.S. Food and Drug Administration (FDA) in sending warning letters to five companies that may be making false or unsubstantiated claims that their products can cure, treat, mitigate, or prevent infertility and other reproductive disorders in violation of...
The Federal Trade Commission announced that 30 more marketers nationwide have stopped making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. The marketers removed these claims after receiving FTC warning letters...
In testimony today before the Senate Commerce Committee’s Subcommittee on Consumer Protection, Product Safety, and Data Security, the Federal Trade Commission provided an update on its work to protect consumers from scams and frauds related to the COVID-19 pandemic.
In April 2021, the FTC charged St. Louis-based chiropractor Eric Anthony Nepute and his company Quickwork LLC with violating the COVID-19 Consumer Protection Act and the Federal Trade Commission Act, by deceptively marketing products containing vitamin D and zinc as scientifically...

Pages